Biomarker Research for Personalized Medicine
NCT01488591 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2013-05-31
Summary
The aim of this study :
1. Through the study of genes of protein, transporter, translator and epigenome investigating the effect of anti-cancer treatment or the key factor of the MDR (Multidrug resistance) on the blood cancer patients who are under the anti-cancer sork treatment
2. Giving a service of anticancer medicine therapeutic drug monitoring (TDM) and genotyping
Conditions
- Hematologic Neoplasms
Sponsors & Collaborators
-
Inje University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-04-30
Countries
- South Korea
Study Locations
More Related Trials
-
Genetic Characteristics of Metastatic Breast Cancer Patients
NCT04258735 ·Status: UNKNOWN ·Phase: NA
-
Genome Sequencing in Refractory Breast Cancer to Molecular Targeted Therapy and Young Breast Cancer
NCT02597179 ·Status: UNKNOWN
-
Genome Wide SNP Array-based Approach to Detect Micro-cytogenetic Lesions and KIT Mutation to Improve Treatment Outcomes in Patients With Core-binding Factor Positive Acute Myeloid Leukemia
NCT01066286 ·Status: UNKNOWN
-
Liquid Biopsy in Monitoring the Therapeutic Efficacy of Targeted Therapy in Advanced/Metastatic Gastric Cancer
NCT02610218 ·Status: UNKNOWN
-
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer
NCT02688517 ·Status: RECRUITING
-
Clinical Benefit of Genetic Biomarkers for Guiding Treatment Decisions in Oncology Drugs
NCT02458040 ·Status: WITHDRAWN
-
Screening Gene Mutations in Myeloid Cancers by Next Generation Sequencing to Improve Treatment Results
NCT04060485 ·Status: UNKNOWN
-
Clinical Study of Pan-cancer DNA Methylation Test in Plasma
NCT05685524 ·Status: UNKNOWN
-
S8600-S9031-S9333-A, Study of DNA in Samples From Patients With Acute Myeloid Leukemia
NCT01434329 ·Status: COMPLETED
-
ctDNA Screening in Advanced HER2 Positive Gastric Cancer
NCT04520295 ·Status: UNKNOWN
-
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
NCT05334069 ·Status: RECRUITING
-
Biology and Genetics of Smouldering Myeloma
NCT05047107 ·Status: UNKNOWN
-
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
NCT04985357 ·Status: WITHDRAWN
-
Genetic Mutations in Blood and Tissue Samples in Predicting Response to Treatment in Patients With Locally Advanced Rectal Cancer Undergoing Chemoradiation
NCT02132858 ·Status: COMPLETED
-
Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques
NCT07035587 ·Status: RECRUITING
-
c-MET Inhibitor in Advanced Solid Tumors With c-MET Gene Aberration
NCT05882292 ·Status: RECRUITING ·Phase: PHASE2
-
AssesSment of Early-deteCtion basEd oN liquiD Biopsy in Hepatobiliary Cancer Malignancies
NCT04835675 ·Status: COMPLETED
-
Biology Studies of Hematologic Cancers
NCT00923442 ·Status: ENROLLING_BY_INVITATION
-
Biomarker Changes in Samples From Young Patients With Acute Myeloid Leukemia
NCT01139931 ·Status: COMPLETED
-
Clinical Sequencing Project for Metastatic Cancer Patients for Personalized Cancer Clinic.
NCT02593578 ·Status: UNKNOWN
-
PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine
NCT05697198 ·Status: COMPLETED
-
Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research
NCT05539677 ·Status: RECRUITING
-
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
NCT02269592 ·Status: RECRUITING
-
Detection Evaluation of a Novel Blood-based DNA Methylation Assay in Early-stage Hepatocellular Carcinoma Patients
NCT05343832 ·Status: UNKNOWN
-
Pan-tumor MRD Study
NCT06605404 ·Status: RECRUITING